IBDEI1LY ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28897,1,2,0)
 ;;=2^596.81
 ;;^UTILITY(U,$J,358.3,28897,1,5,0)
 ;;=5^Infection of Cystostomy
 ;;^UTILITY(U,$J,358.3,28897,2)
 ;;=^340556
 ;;^UTILITY(U,$J,358.3,28898,0)
 ;;=233.4^^181^1839^13
 ;;^UTILITY(U,$J,358.3,28898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28898,1,2,0)
 ;;=2^233.4
 ;;^UTILITY(U,$J,358.3,28898,1,5,0)
 ;;=5^Prostate Carcinoma in Situ
 ;;^UTILITY(U,$J,358.3,28898,2)
 ;;=^267739
 ;;^UTILITY(U,$J,358.3,28899,0)
 ;;=185.^^181^1839^4
 ;;^UTILITY(U,$J,358.3,28899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28899,1,2,0)
 ;;=2^185.
 ;;^UTILITY(U,$J,358.3,28899,1,5,0)
 ;;=5^Cancer, Prostate, Primary
 ;;^UTILITY(U,$J,358.3,28899,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,28900,0)
 ;;=198.82^^181^1839^5
 ;;^UTILITY(U,$J,358.3,28900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28900,1,2,0)
 ;;=2^198.82
 ;;^UTILITY(U,$J,358.3,28900,1,5,0)
 ;;=5^Cancer, Prostate, Secondary
 ;;^UTILITY(U,$J,358.3,28900,2)
 ;;=^267339
 ;;^UTILITY(U,$J,358.3,28901,0)
 ;;=V10.46^^181^1839^7
 ;;^UTILITY(U,$J,358.3,28901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28901,1,2,0)
 ;;=2^V10.46
 ;;^UTILITY(U,$J,358.3,28901,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,28901,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,28902,0)
 ;;=222.2^^181^1839^3
 ;;^UTILITY(U,$J,358.3,28902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28902,1,2,0)
 ;;=2^222.2
 ;;^UTILITY(U,$J,358.3,28902,1,5,0)
 ;;=5^Benign Neop Prostate
 ;;^UTILITY(U,$J,358.3,28902,2)
 ;;=^267657
 ;;^UTILITY(U,$J,358.3,28903,0)
 ;;=600.00^^181^1839^1
 ;;^UTILITY(U,$J,358.3,28903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28903,1,2,0)
 ;;=2^600.00
 ;;^UTILITY(U,$J,358.3,28903,1,5,0)
 ;;=5^BPH
 ;;^UTILITY(U,$J,358.3,28903,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,28904,0)
 ;;=600.01^^181^1839^2
 ;;^UTILITY(U,$J,358.3,28904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28904,1,2,0)
 ;;=2^600.01
 ;;^UTILITY(U,$J,358.3,28904,1,5,0)
 ;;=5^BPH w/ LUTS
 ;;^UTILITY(U,$J,358.3,28904,2)
 ;;=^334256
 ;;^UTILITY(U,$J,358.3,28905,0)
 ;;=600.10^^181^1839^10
 ;;^UTILITY(U,$J,358.3,28905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28905,1,2,0)
 ;;=2^600.10
 ;;^UTILITY(U,$J,358.3,28905,1,5,0)
 ;;=5^Nodular Prostate
 ;;^UTILITY(U,$J,358.3,28905,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,28906,0)
 ;;=600.90^^181^1839^9
 ;;^UTILITY(U,$J,358.3,28906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28906,1,2,0)
 ;;=2^600.90
 ;;^UTILITY(U,$J,358.3,28906,1,5,0)
 ;;=5^Hyperplasia,Unspec
 ;;^UTILITY(U,$J,358.3,28906,2)
 ;;=^334278
 ;;^UTILITY(U,$J,358.3,28907,0)
 ;;=600.91^^181^1839^8
 ;;^UTILITY(U,$J,358.3,28907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28907,1,2,0)
 ;;=2^600.91
 ;;^UTILITY(U,$J,358.3,28907,1,5,0)
 ;;=5^Hyperplasia w/ LUTS
 ;;^UTILITY(U,$J,358.3,28907,2)
 ;;=^334258
 ;;^UTILITY(U,$J,358.3,28908,0)
 ;;=601.0^^181^1839^14
 ;;^UTILITY(U,$J,358.3,28908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28908,1,2,0)
 ;;=2^601.0
 ;;^UTILITY(U,$J,358.3,28908,1,5,0)
 ;;=5^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,28908,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,28909,0)
 ;;=601.1^^181^1839^15
 ;;^UTILITY(U,$J,358.3,28909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28909,1,2,0)
 ;;=2^601.1
 ;;^UTILITY(U,$J,358.3,28909,1,5,0)
 ;;=5^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,28909,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,28910,0)
 ;;=601.2^^181^1839^11
 ;;^UTILITY(U,$J,358.3,28910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28910,1,2,0)
 ;;=2^601.2
 ;;^UTILITY(U,$J,358.3,28910,1,5,0)
 ;;=5^Prostate Abscess
 ;;^UTILITY(U,$J,358.3,28910,2)
 ;;=^270416
